Total Cholesterol: what your result means.

Total cholesterol is the combined measure of all cholesterol carried in your blood. LDL, HDL and other lipoproteins in a single number. It is the oldest and most familiar lipid marker, and remains the entry point to cardiovascular risk assessment.

Why Total Cholesterol matters

Decades of data across hundreds of thousands of people show a continuous, graded relationship between total cholesterol and cardiovascular mortality. There is no sharp threshold where risk 'switches on'. Its limitation is that it blends protective HDL with atherogenic particles, which is why modern assessment pairs it with ApoB and the full lipid fractionation.

Associated risks when out of range: Elevated atherogenic risk when driven by high LDL/ApoB. Misleading if elevated due to high HDL (benign elevation). Very low TC (<3.5 mmol/L) may signal malnutrition or liver dysfunction.

What the clinical evidence shows

The evidence base behind how the HodieLabs Evidence-Based Clinical Library interprets Total Cholesterol, from randomised trials, prospective cohorts and genetic (Mendelian randomisation) studies. Full citations in the reference list below.

• Prospective Studies Collaboration (The Lancet 2007): pooled data from 61 cohorts and ~900,000 adults showed a continuous, graded relationship between total cholesterol and ischaemic heart disease mortality across the entire range, with no threshold below which lower stopped being better.
• MRFIT screening cohort (Stamler et al. JAMA 1986): among ~360,000 screened men, coronary death rates rose continuously with total cholesterol, foundational evidence that 'average' cholesterol in a modern population is not the same as biologically optimal.
• Modern guideline synthesis (ESC/EAS 2019): total cholesterol now serves as the gateway measure, with risk decisions made on the fractionated picture, LDL-C, non-HDL and ApoB, because a single combined number can conceal offsetting components.

Evidence-based reference ranges

The HodieLabs Evidence-Based Clinical Library interprets Total Cholesterol against published clinical authority standards, never arbitrary "optimal" ranges. Measured in mmol/L:

Band	Range (mmol/L)
Optimal	<5.0 mmol/L
Borderline	5.0–5.5 mmol/L
High	5.6–7.5 mmol/L
Very high	>7.5 mmol/L

Clinical interpretation

• TC alone is a poor predictor. Always interpret with LDL, HDL, TG, and ApoB.
• A high TC driven by high HDL is clinically different from one driven by high LDL.
• Non-HDL cholesterol (TC minus HDL) is a better atherogenic marker than TC alone.

What improves it: the evidence-based levers

• Diet quality
• Exercise
• Weight optimisation

Recommended testing frequency: Annual, as part of a comprehensive panel. Single markers are always interpreted in context.

How Total Cholesterol testing works at HodieLabs

Total Cholesterol is measured in every Health Blueprint at our Melbourne Preventative Health & Longevity Clinic, interpreted by a doctor against the guideline-cited ranges above and tracked over time through your HodieLabs membership.

References

1. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies. Lancet. 2007;370:1829–1839.
2. Stamler J, et al. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? (MRFIT). JAMA. 1986;256:2823–2828.
3. Mach F, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2020;41:111–188.

This page is general information from the HodieLabs Evidence-Based Clinical Library, not medical advice. Speak with your GP about what testing and care is appropriate for you.